Title of article :
New generation of antidepressants in pregnant women
Author/Authors :
Kashani، Ladan نويسنده Department of Infertility, Arash Hospital, Tehran University of Medical Sciences, Tehran, Iran. Kashani, Ladan , Akhondzadeh، Shahin نويسنده ,
Issue Information :
فصلنامه با شماره پیاپی 0 سال 2007
Pages :
5
From page :
1
To page :
5
Abstract :

Although pregnancy was once thought to protect against psychiatric disorders, gravid and non gravid women have similar risks for major depression, at 10% to 15%. Both depression and antidepressant treatment during pregnancy have been associated with risks. Few medications have been proved unequivocally safe during pregnancy. Although certain antidepressants have not been linked with an increased risk of birth defects or impaired development including bupropion, citalopram, escitalopram and venlafaxine, the latest studies arenʹt necessarily reassuring. As researchers continue to learn more about antidepressants, the risks and benefits of taking the drugs during pregnancy must be weighed carefully on a case-by-case basis. This review discusses about the use of new generation of antidepressants in pregnancy

Journal title :
Journal of Family and Reproductive Health
Serial Year :
2007
Journal title :
Journal of Family and Reproductive Health
Record number :
2394194
Link To Document :
بازگشت